Home » Newsletters » BioWorld Asia

BioWorld Asia

April 22, 1998

View Archived Issues

EU Controversy Growing Over GMO Products, Regulations

DNA Mimic Seen As Antisense Against Bacterial Resistance

British Biotech Fires Executive For Disclosing Inside Information

Australian Doctors To Conduct Photodynamic Trials In Cancer

EC Makes Progress Report On Publicly Funded Research

BioSignal To Test Astra's Pain Research Compounds

Israeli Scientists Discover Antioxidant-Producing Bacteria

Roslin Using Dolly Technology As Basis For Start-Up Firm

SmithKline, Amrad Collaborate On Vaccine For Rotavirus

EU Releases Guideline On Biotech Test Procedures

Other News to Note

Insurance Firms Offering More Protection For Biotech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...